$0.752800
0.034.56%
At Close: -
$0.744800
-0.0080-1.06%
After Hours: Aug 23, 8:00 AM EDT
15 minutes delayed
Passage Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Passage Bio using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.26 | $-0.31 | 16.1 % |
Mar 2024 | 2024-05-14 | $-0.30 | $-0.36 | 16.7 % |
Dec 2023 | 2024-03-04 | $-0.30 | $-0.40 | 25.0 % |
Sep 2023 | 2023-11-13 | $-0.49 | $-0.46 | -6.52 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Passage Bio (PASG) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.26, which beat the estimate of $-0.31.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.